FDA Approval: Blinatumomab for patients with B-cell precursor acute lymphoblastic leukemia in morphologic remission with minimal residual disease
Jen, Emily Y., Xu, Qing, Schetter, Aaron, Przepiorka, Donna, Shen, Yuan Li, Roscoe, Donna, Sridhara, Rajeshwari, Deisseroth, Albert, Philip, Reena, Farrell, Ann T., Pazdur, RichardLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-18-2337
Date:
September, 2018
File:
PDF, 536 KB
english, 2018